dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with ascorbic acid in 1 studies
Studies (dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination) | Trials (dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination) | Recent Studies (post-2010) (dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
---|---|---|---|---|---|
219 | 84 | 3 | 45,261 | 2,497 | 11,176 |
Protein | Taxonomy | dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination (IC50) | ascorbic acid (IC50) |
---|---|---|---|
Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
Urease | Canavalia ensiformis (jack bean) | 8.59 | |
Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amirkhanian, JD; Cross, CE; Halliwell, B; Helbock, H; Merritt, TA | 1 |
1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and ascorbic acid
Article | Year |
---|---|
Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.
Topics: Amniotic Fluid; Ascorbic Acid; Biological Products; Drug Combinations; Fatty Alcohols; Glutathione; Humans; Hypochlorous Acid; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Surface Tension; Surface-Active Agents; Time Factors | 1993 |